Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® Ebola specialty page provides Ebola-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

EBOLA NEWS - Page 2

Proposed Budget Cuts to Global Health Might Be Bad Medicine for State Economies: Public Health Watch Report
A new report by Global Health Technologies Coalition assesses the economic impact of cuts to global health R&D on the economies of US states.
Single-Dose Of Ebola Vaccine May Provide Protection Against Deadly Disease for Up to 2 Years
A recent study has found that a single-dose of Merck's Ebola vaccine delivers antibodies that can last for 1 to 2 years.
Gates Calls for Global Pandemic Prep & Planning During NEJM's Annual Shattuck Lecture: Public Health Watch
The tech mogul shares that world leaders need to prepare for the next pandemic—whatever the root cause—including plans for mobilizing military, health, and other resources while coordinating efforts with private industry.
CDC Requests New High Containment Lab
The US Centers for Disease Control and Prevention (CDC) has requested funds for a new high containment lab; let's give it to them.
CDC's Uganda-Based Viral Surveillance Program Significantly Reduces Disease Detection Time
The program can detect viral hemorrhagic fevers about 12 days faster than previous efforts.
Global Virome Project Will Spend Next 10 Years Identifying Unknown Viruses in the Wild
The Global Virome Project is set to launch in 2018, and will spend the next 10 years working to identify as many as 827,000 unknown viruses in the wild.
Top Infectious Disease News of the Week—February 11, 2018
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
Ebola Survivors Still Producing Antibodies 40 Years After First Outbreak
Forty years after the first Ebola outbreak in the Democratic Republic of Congo, investigators find that a small group of survivors are still producing virus-fighting antibodies.
FEATURED
Big advances in treatment can